HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sharif, M. N. Articles by Eckhardt, L. A. Search for Related Content PubMed PubMed Citation Articles by Sharif, M. N. Articles by Eckhardt, L. A.

Unique Function for Carboxyl-Terminal Domain of Oct-2 in Ig-Secreting Cells¹

Department of Biological Sciences, Hunter College, and Graduate School of City University of New York, New York, NY 10021

The activity of Ig gene promoters and enhancers is regulated by two related transcription factors, Oct-1 (ubiquitous) and Oct-2 (B lineage specific), which bind the octamer motif (ATTTGCAT) present in these elements. As Ig promoter-binding factors, Oct-1 and Oct-2 each work together with a B lymphocyte-specific cofactor OCA-B/OBF-1/Bob-1 that interacts with them through their POU (DNA-binding) domains. Because both can mediate Ig promoter activity in B cells, there has been some question as to whether these two octamer-binding factors serve distinct functions in lymphocytes. We have shown previously that the silencing of B lymphocyte-specific genes in plasmacytoma x T lymphoma hybrids can be prevented by preserving Oct-2 expression. The pronounced effect of this transcription factor on the phenotype of plasmacytoma x T lymphoma hybrids established a critical role for Oct-2 not only in maintaining Ig gene expression, but in maintaining the overall genetic program of Ig-secreting cells. In the present study, we have explored the functional differences between Oct-1 and Oct-2 using chimeric Oct-1/Oct-2 proteins in cell fusion assays. Our results provide further evidence for an essential role for Oct-2 in Ig-secreting cells and identify the C-terminal domain of Oct-2 as responsible for its unique function in these cells.

This article has been cited by other articles:

				I. Ahmad, D. C. Hoessli, E. Walker-Nasir, S. M. Rafik, A. R. Shakoori, and Nasir-ud-Din Oct-2 DNA binding transcription factor: functional consequences of phosphorylation and glycosylation Nucleic Acids Res., January 8, 2006; 34(1): 175 - 184. [Abstract] [Full Text] [PDF]

				L. M. Corcoran, F. Koentgen, W. Dietrich, M. Veale, and P. O. Humbert All Known In Vivo Functions of the Oct-2 Transcription Factor Require the C-Terminal Protein Domain J. Immunol., March 1, 2004; 172(5): 2962 - 2969. [Abstract] [Full Text] [PDF]

				M. A. Sepulveda, A. V. Emelyanov, and B. K. Birshtein NF-{kappa}B and Oct-2 Synergize to Activate the Human 3' Igh hs4 Enhancer in B Cells J. Immunol., January 15, 2004; 172(2): 1054 - 1064. [Abstract] [Full Text] [PDF]

				M. Salas and L. A. Eckhardt Critical Role for the Oct-2/OCA-B Partnership in Ig-Secreting Cells J. Immunol., December 15, 2003; 171(12): 6589 - 6598. [Abstract] [Full Text] [PDF]